Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
Charles River Laboratories International (NYSE: CRL) has announced its participation in two upcoming investor conferences. The company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5th at 9:15 a.m. EDT and the Baird 2024 Global Healthcare Conference on September 10th at 10:15 a.m. EDT.
During these presentations, management will provide an overview of Charles River's strategic focus, business developments, and recent trends. Investors and interested parties can access live webcasts of both presentations through the Investor Relations section of Charles River's website at ir.criver.com. Webcast replays will be available for at least two weeks after each presentation.
Charles River Laboratories International (NYSE: CRL) ha annunciato la sua partecipazione a due prossimi conferenze per investitori. L'azienda presenterà alla 22ª Conferenza Annuale Globale sulla Sanità di Morgan Stanley il 5 settembre alle 9:15 EDT e alla Conferenza Globale sulla Sanità 2024 di Baird il 10 settembre alle 10:15 EDT.
Durante queste presentazioni, la direzione fornirà una panoramica sul foco strategico, gli sviluppi aziendali e le recenti tendenze di Charles River. Gli investitori e le parti interessate possono accedere alle webcasts in diretta di entrambe le presentazioni attraverso la sezione Relazioni con gli Investitori del sito web di Charles River all'indirizzo ir.criver.com. Le registrazioni delle webcasts saranno disponibili per almeno due settimane dopo ciascuna presentazione.
Charles River Laboratories International (NYSE: CRL) ha anunciado su participación en dos próximas conferencias para inversores. La compañía presentará en la 22ª Conferencia Global Anual de Salud de Morgan Stanley el 5 de septiembre a las 9:15 a.m. EDT y en la Conferencia Global de Salud 2024 de Baird el 10 de septiembre a las 10:15 a.m. EDT.
Durante estas presentaciones, la dirección proporcionará una visión general del enfoque estratégico, los desarrollos comerciales y las tendencias recientes de Charles River. Los inversores y partes interesadas pueden acceder a las transmisiones en vivo de ambas presentaciones a través de la sección de Relaciones con Inversores del sitio web de Charles River en ir.criver.com. Las repeticiones de las transmisiones estarán disponibles durante al menos dos semanas después de cada presentación.
찰스 리버 연구소 국제(뉴욕 증권 거래소: CRL)는 두 가지 투자자 회의에 참가할 것이라고 발표했습니다. 회사는 9월 5일 오전 9시 15분 EDT에 모건 스탠리 제22회 연례 글로벌 헬스케어 회의와 9월 10일 오전 10시 15분 EDT에 베어드 2024 글로벌 헬스케어 회의에서 발표할 예정입니다.
이 발표 동안 경영진은 찰스 리버의 전략적 초점, 사업 개발 및 최근 동향에 대한 개요를 제공할 것입니다. 투자자 및 관심 있는 당사자는 찰스 리버 웹사이트의 투자자 관계 섹션(ir.criver.com)을 통해 두 발표의 실시간 웹캐스트에 접근할 수 있습니다. 웹캐스트 재생은 각 발표 후 최소 2주간 제공될 예정입니다.
Charles River Laboratories International (NYSE: CRL) a annoncé sa participation à deux prochaines conférences pour investisseurs. L'entreprise présentera à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 5 septembre à 9h15 EDT et à la Conférence Mondiale sur la Santé 2024 de Baird le 10 septembre à 10h15 EDT.
Lors de ces présentations, la direction fournira un aperçu du focal stratégique, des développements commerciaux et des tendances récentes de Charles River. Les investisseurs et les parties intéressées peuvent accéder aux webcasts en direct des deux présentations via la section Relations Investisseurs du site Web de Charles River à l'adresse ir.criver.com. Les rediffusions des webcasts seront disponibles pendant au moins deux semaines après chaque présentation.
Charles River Laboratories International (NYSE: CRL) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekanntgegeben. Das Unternehmen wird am 5. September um 9:15 Uhr EDT auf der 22. Jahrestagung für globale Gesundheitsversorgung von Morgan Stanley präsentieren und am 10. September um 10:15 Uhr EDT auf der Baird 2024 Global Health Conference.
Während dieser Präsentationen wird das Management einen Überblick über die strategischen Schwerpunkte, Unternehmensentwicklungen und jüngste Trends von Charles River geben. Investoren und Interessierte können die Live-Webcasts beider Präsentationen über den Bereich Investor Relations auf der Website von Charles River unter ir.criver.com abrufen. Die Wiederholungen der Webcasts werden mindestens zwei Wochen nach jeder Präsentation verfügbar sein.
- None.
- None.
- Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, at 9:15 a.m. EDT; and
- Baird 2024 Global Healthcare Conference on Tuesday, September 10th, at 10:15 a.m. EDT.
Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903345318/en/
Investor Relations Contact:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When is Charles River Laboratories (CRL) presenting at the Morgan Stanley Healthcare Conference?
What date is Charles River Laboratories (CRL) presenting at the Baird Global Healthcare Conference?
How can investors access Charles River Laboratories' (CRL) conference presentations?
How long will the webcast replays of Charles River Laboratories' (CRL) presentations be available?
What topics will Charles River Laboratories (CRL) cover in their investor conference presentations?
